Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Brain-selective nicotinic agonist RJR-1734 enhances ACh release

July 19, 2000

New antiemetics from Takeda prove effective in range of animal models

July 18, 2000

Potential new antimigraine agents with an indole structure reported by Lilly

July 18, 2000

Nicotinic acetylcholine receptor ligands under study at major French laboratory

July 18, 2000

Sch-58261, an adenosine A2A antagonist, exerts beneficial effects in rat models of HD and PD

July 18, 2000

NK1 antagonists alter behavior in rodent models of antidepressant activity

July 18, 2000

Antidepressant EMD-68843 alters sleep in humans

July 18, 2000

Panacea and Case Western to collaborate on AD models

July 18, 2000

Takeda's new neuroprotectants useful for Alzheimer's disease and Parkinson's disease

July 17, 2000

Analgesic activity described for substituted cycloheptenes synthesized at Gruenenthal

July 17, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 17, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Viva in vivo! At EHA, in vivo CAR T data continues to impress
BioWorld
Treatment with first-generation CAR T cells regularly sent patients to the intensive care unit. Now, investigators are envisioning a future where CAR T treatment...